A. Ballaz

发表

Systolic blood pressure and mortality in acute symptomatic pulmonary embolism.

R. Yusen, D. Jiménez, M. Monreal, 2019, International journal of cardiology.

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

L. Bertoletti, M. Monreal, I. Mahé, 2015, PloS one.

Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

F. Pomero, L. Mazzolai, P. Prandoni, 2021, Journal of the American Heart Association.

Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT.

J. Zamorano, D. Jiménez, C. Dellas, 2018, International journal of cardiology.

Predicting 1-year mortality after hospitalization for community-acquired pneumonia

U. Aguirre, J. Quintana, A. Uranga, 2018, PloS one.

Tuberculosis screening programme for undocumented immigrant teenagers using the QuantiFERON®-TB Gold In-Tube test

U. Aguirre, A. Ballaz, Ane Antón, 2015 .

Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry

L. Bertoletti, M. Monreal, B. Bikdeli, 2020, Journal of Thrombosis and Thrombolysis.

Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

F. Dentali, G. Lessiani, L. Mazzolai, 2017, Research and practice in thrombosis and haemostasis.

Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.

W. Ageno, M. Monreal, A. Tufano, 2018, Thrombosis research.

Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry

L. Mazzolai, C. Font, M. Monreal, 2017, Thrombosis and Haemostasis.

Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry

G. Lessiani, S. Parikh, P. Prandoni, 2018, Journal of the American Heart Association.

Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism.

J. Barberà, D. Jiménez, R. Otero, 2011, Thrombosis research.

D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

P. Prandoni, L. Bertoletti, P. Verhamme, 2020, Journal of internal medicine.

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

M. Monreal, I. Mahé, D. Farge-Bancel, 2022, Research and practice in thrombosis and haemostasis.

Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation

L. Mazzolai, M. Monreal, A. Ballaz, 2022, British journal of haematology.

First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

L. Mazzolai, P. Prandoni, E. Grandone, 2020 .

Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi

P. Verhamme, D. Jiménez, M. Monreal, 2020, European Respiratory Journal.

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

M. Monreal, A. Riera-Mestre, P. Cerdà, 2019, Orphanet Journal of Rare Diseases.

Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia

U. Aguirre, J. Quintana, A. Uranga, 2022, Archivos de Bronconeumología.

[Study of contacts in children and adolescents using the QuantiFERON®-TB Gold In-Tube].

U. Aguirre, A. Ballaz, I. Pocheville, 2011, Anales de pediatria.

Unsuspected pulmonary embolism in patients with cancer.

M. Monreal, A. Ballaz, R. Malý, 2012, Thrombosis research.

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

P. Prandoni, L. Bertoletti, P. Verhamme, 2021, Internal and Emergency Medicine.

Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial.

A. Agustí, R. Yusen, L. Bertoletti, 2021, JAMA.

Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

F. Dentali, L. Mazzolai, P. Prandoni, 2019, Scientific Reports.

Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.

M. Monreal, F. Klok, I. Mahé, 2019, Thrombosis research.

Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.

L. Jara-Palomares, M. Alfonso, R. Otero, 2023, Thrombosis research.

Impact of Anxiety and Depression on Disease Control and Quality of Life in Asthma Patients

I. Urrutia, U. Aguirre, C. Esteban, 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

Prevalence of silicosis in a marble factory after exposure to quartz conglomerates.

I. Urrutia, S. Pascual, A. Ballaz, 2011, Archivos de bronconeumologia.

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

L. Jara-Palomares, A. Maestre, G. Vidal, 2023, Research and Practice in Thrombosis and Haemostasis.

Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism.

D. Jiménez, M. Monreal, B. Bikdeli, 2023, Archivos de Bronconeumologia.

High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism.

R. Yusen, R. Otero, B. Bikdeli, 2023, JAMA cardiology.

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

A. Agustí, R. Yusen, L. Bertoletti, 2019, Clinical cardiology.